A new article published in the Brain Stimulation journal, entitled “Guidelines for TMS/tES clinical services and research through the COVID-19 pandemic” highlights the advantage of robotics in TMS administration during the COVID-19 pandemic: “Robotic TMS provides some opportunity for TMS administration with operators further removed from participants (easily by 2 m/6 feet except for brief localization to navigation, though the participant can be trained to do this).”  Read more.


A new standard for Transcranial Magnetic Stimulation


After having developed and commercialized TMS-Robot, the first robot specifically designed for Transcranial Magnetic Stimulation (TMS), Axilum Robotics enlarges its range of robotic solutions for TMS with TMS-Cobot, intergrating collaborative robotic or « cobot » technology

TMS-Robot and TMS-Cobot allow to automate this non-invasive, painless brain stimulation technique, usually implemented manually, with a high level of safety and with improved accuracy and repeatability.

With its partners, Axilum Robotics gives a unique opportunity to healthcare professionals and researchers to improve the execution of their TMS procedures, using different robotic solutions, while saving the operator from a repetitive and painful task

Axilum Robotics TMS-Cobot is a CE marked medical device, has FDA 510(k) clearance in the USA and TGA approval in Australia.

Axilum Robotics TMS-Robot is a device available for medical or scientific investigation purposes only.